annual shareholders equity:
$747.00M+$317.83M(+74.06%)Summary
- As of today (July 3, 2025), CLDX annual stockholders equity is $747.00 million, with the most recent change of +$317.83 million (+74.06%) on December 31, 2024.
- During the last 3 years, CLDX annual shareholders equity has risen by +$327.53 million (+78.08%).
- CLDX annual shareholders equity is now at all-time high.
Performance
CLDX Shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly shareholders equity:
$702.98M-$44.02M(-5.89%)Summary
- As of today (July 3, 2025), CLDX quarterly stockholders equity is $702.98 million, with the most recent change of -$44.02 million (-5.89%) on March 31, 2025.
- Over the past year, CLDX quarterly shareholders equity has dropped by -$135.63 million (-16.17%).
- CLDX quarterly shareholders equity is now -16.17% below its all-time high of $838.61 million, reached on March 31, 2024.
Performance
CLDX quarterly shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Shareholders equity Formula
Shareholders Equity = Total Assets − Total Liabilities
CLDX Shareholders equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +74.1% | -16.2% |
| 3 y3 years | +78.1% | +76.6% |
| 5 y5 years | +694.5% | +739.9% |
CLDX Shareholders equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +129.0% | -16.2% | +184.9% |
| 5 y | 5-year | at high | +694.5% | -16.2% | +285.7% |
| alltime | all time | at high | >+9999.0% | -16.2% | +5140.5% |
CLDX Shareholders equity History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $702.98M(-5.9%) |
| Dec 2024 | $747.00M(+74.1%) | $747.00M(-4.9%) |
| Sep 2024 | - | $785.90M(-3.4%) |
| Jun 2024 | - | $813.66M(-3.0%) |
| Mar 2024 | - | $838.61M(+95.4%) |
| Dec 2023 | $429.17M(+31.6%) | $429.17M(+74.0%) |
| Sep 2023 | - | $246.72M(-11.1%) |
| Jun 2023 | - | $277.54M(-8.3%) |
| Mar 2023 | - | $302.74M(-7.2%) |
| Dec 2022 | $326.20M(-22.2%) | $326.20M(-5.6%) |
| Sep 2022 | - | $345.42M(-5.4%) |
| Jun 2022 | - | $365.09M(-8.3%) |
| Mar 2022 | - | $398.10M(-5.1%) |
| Dec 2021 | $419.48M(+100.4%) | $419.48M(-3.9%) |
| Sep 2021 | - | $436.71M(+139.6%) |
| Jun 2021 | - | $182.28M(-6.1%) |
| Mar 2021 | - | $194.17M(-7.3%) |
| Dec 2020 | $209.36M(+122.7%) | $209.36M(-9.0%) |
| Sep 2020 | - | $229.97M(-3.6%) |
| Jun 2020 | - | $238.44M(+184.9%) |
| Mar 2020 | - | $83.70M(-11.0%) |
| Dec 2019 | $94.03M(-24.2%) | $94.03M(-7.3%) |
| Sep 2019 | - | $101.38M(-7.5%) |
| Jun 2019 | - | $109.63M(-2.7%) |
| Mar 2019 | - | $112.69M(-9.2%) |
| Dec 2018 | $124.06M(-47.5%) | $124.06M(-3.2%) |
| Sep 2018 | - | $128.13M(+0.1%) |
| Jun 2018 | - | $128.05M(-4.5%) |
| Mar 2018 | - | $134.08M(-43.3%) |
| Dec 2017 | $236.37M(-10.9%) | $236.37M(+7.9%) |
| Sep 2017 | - | $219.15M(-5.3%) |
| Jun 2017 | - | $231.46M(-6.6%) |
| Mar 2017 | - | $247.84M(-6.6%) |
| Dec 2016 | $265.43M(-8.5%) | $265.43M(+22.3%) |
| Sep 2016 | - | $217.09M(-7.5%) |
| Jun 2016 | - | $234.71M(-9.7%) |
| Mar 2016 | - | $260.03M(-10.4%) |
| Dec 2015 | $290.11M(+37.1%) | $290.11M(-9.0%) |
| Sep 2015 | - | $318.63M(-7.9%) |
| Jun 2015 | - | $345.88M(-7.9%) |
| Mar 2015 | - | $375.55M(+77.4%) |
| Dec 2014 | $211.66M(-33.8%) | $211.66M(-11.6%) |
| Sep 2014 | - | $239.37M(-9.8%) |
| Jun 2014 | - | $265.31M(-9.1%) |
| Mar 2014 | - | $291.85M(-8.7%) |
| Dec 2013 | $319.80M(+233.9%) | $319.80M(+104.0%) |
| Sep 2013 | - | $156.75M(-11.5%) |
| Jun 2013 | - | $177.09M(-9.2%) |
| Mar 2013 | - | $194.94M(+103.5%) |
| Dec 2012 | $95.77M(+39.4%) | $95.77M(+5.2%) |
| Sep 2012 | - | $91.02M(-3.7%) |
| Jun 2012 | - | $94.55M(-12.4%) |
| Mar 2012 | - | $107.89M(+57.0%) |
| Dec 2011 | $68.72M(-8.7%) | $68.72M(-14.8%) |
| Sep 2011 | - | $80.67M(-12.3%) |
| Jun 2011 | - | $92.00M(+39.9%) |
| Mar 2011 | - | $65.78M(-12.6%) |
| Dec 2010 | $75.25M(+2.0%) | $75.25M(+44.7%) |
| Sep 2010 | - | $52.02M(-13.3%) |
| Jun 2010 | - | $60.00M(-12.4%) |
| Mar 2010 | - | $68.46M(-7.2%) |
| Dec 2009 | $73.77M(+306.8%) | $73.77M(-3393.2%) |
| Sep 2009 | - | -$2.24M(-152.1%) |
| Jun 2009 | - | $4.30M(-63.5%) |
| Mar 2009 | - | $11.79M(-35.0%) |
| Dec 2008 | $18.13M(-1702.1%) | $18.13M(-23.9%) |
| Sep 2008 | - | $23.84M(-19.0%) |
| Jun 2008 | - | $29.43M(+4.5%) |
| Mar 2008 | - | $28.16M(-2588.1%) |
| Dec 2007 | -$1.13M(-152.4%) | -$1.13M(-91.9%) |
| Sep 2007 | - | -$13.95M(+57.9%) |
| Jun 2007 | - | -$8.83M(+162.5%) |
| Mar 2007 | - | -$3.36M(-255.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2006 | $2.16M(-89.7%) | $2.16M(-71.9%) |
| Sep 2006 | - | $7.70M(-39.8%) |
| Jun 2006 | - | $12.80M(-29.6%) |
| Mar 2006 | - | $18.19M(-12.9%) |
| Dec 2005 | $20.89M(-45.6%) | $20.89M(-15.4%) |
| Sep 2005 | - | $24.69M(-15.0%) |
| Jun 2005 | - | $29.05M(-13.7%) |
| Mar 2005 | - | $33.66M(-12.4%) |
| Dec 2004 | $38.41M(+37.6%) | $38.41M(-8.5%) |
| Sep 2004 | - | $41.98M(-7.9%) |
| Jun 2004 | - | $45.57M(-7.7%) |
| Mar 2004 | - | $49.39M(+76.9%) |
| Dec 2003 | $27.92M(-10.9%) | $27.92M(-12.5%) |
| Sep 2003 | - | $31.92M(+29.2%) |
| Jun 2003 | - | $24.71M(-11.4%) |
| Mar 2003 | - | $27.90M(-11.0%) |
| Dec 2002 | $31.34M(-30.8%) | $31.34M(-10.2%) |
| Sep 2002 | - | $34.91M(-0.9%) |
| Jun 2002 | - | $35.23M(-12.8%) |
| Mar 2002 | - | $40.39M(-10.8%) |
| Dec 2001 | $45.27M(-16.1%) | $45.27M(+17.5%) |
| Sep 2001 | - | $38.54M(-13.8%) |
| Jun 2001 | - | $44.71M(-11.0%) |
| Mar 2001 | - | $50.22M(-6.9%) |
| Dec 2000 | $53.93M(+209.7%) | $53.93M(+12.1%) |
| Sep 2000 | - | $48.10M(+188.9%) |
| Jun 2000 | - | $16.65M(-13.0%) |
| Mar 2000 | - | $19.14M(+9.9%) |
| Dec 1999 | $17.41M(-7.4%) | $17.41M(-17.1%) |
| Sep 1999 | - | $21.00M(+53.3%) |
| Jun 1999 | - | $13.70M(-14.4%) |
| Mar 1999 | - | $16.00M(-14.9%) |
| Dec 1998 | $18.80M(+198.4%) | $18.80M(-10.9%) |
| Sep 1998 | - | $21.10M(+197.2%) |
| Jun 1998 | - | $7.10M(-17.4%) |
| Mar 1998 | - | $8.60M(+36.5%) |
| Dec 1997 | $6.30M(-59.6%) | $6.30M(-18.2%) |
| Sep 1997 | - | $7.70M(-35.8%) |
| Jun 1997 | - | $12.00M(-12.4%) |
| Mar 1997 | - | $13.70M(-12.2%) |
| Dec 1996 | $15.60M(-2.5%) | $15.60M(-13.3%) |
| Sep 1996 | - | $18.00M(+76.5%) |
| Jun 1996 | - | $10.20M(-28.2%) |
| Mar 1996 | - | $14.20M(-11.3%) |
| Dec 1995 | $16.00M(-9.1%) | $16.00M(+64.9%) |
| Sep 1995 | - | $9.70M(-23.0%) |
| Jun 1995 | - | $12.60M(-17.1%) |
| Mar 1995 | - | $15.20M(-13.6%) |
| Dec 1994 | $17.60M(-39.5%) | $17.60M(-15.4%) |
| Sep 1994 | - | $20.80M(-12.2%) |
| Jun 1994 | - | $23.70M(-10.6%) |
| Mar 1994 | - | $26.50M(-8.9%) |
| Dec 1993 | $29.10M(+47.7%) | $29.10M(+103.5%) |
| Sep 1993 | - | $14.30M(-14.4%) |
| Jun 1993 | - | $16.70M(-8.2%) |
| Mar 1993 | - | $18.20M(-12.9%) |
| Dec 1992 | $19.70M(-14.7%) | - |
| Oct 1992 | - | $20.90M(-5.0%) |
| Jul 1992 | - | $22.00M(-4.8%) |
| Apr 1992 | - | $23.10M(-6.1%) |
| Apr 1992 | $23.10M(+122.1%) | - |
| Jan 1992 | - | $24.60M(-0.8%) |
| Oct 1991 | - | $24.80M(-5.7%) |
| Jul 1991 | - | $26.30M(+152.9%) |
| Apr 1991 | $10.40M(-20.6%) | $10.40M(-1.9%) |
| Jan 1991 | - | $10.60M(-7.0%) |
| Oct 1990 | - | $11.40M(-5.8%) |
| Jul 1990 | - | $12.10M(-7.6%) |
| Apr 1990 | $13.10M(+56.0%) | $13.10M(+32.3%) |
| Jan 1990 | - | $9.90M(+17.9%) |
| Apr 1989 | $8.40M(-9.7%) | $8.40M(-9.7%) |
| Apr 1988 | $9.30M(-10.6%) | $9.30M(-10.6%) |
| Apr 1987 | $10.40M(-516.0%) | $10.40M(-516.0%) |
| Apr 1986 | -$2.50M | -$2.50M |
FAQ
- What is Celldex Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Celldex Therapeutics?
- What is Celldex Therapeutics annual shareholders equity year-on-year change?
- What is Celldex Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Celldex Therapeutics?
- What is Celldex Therapeutics quarterly shareholders equity year-on-year change?
What is Celldex Therapeutics annual stockholders equity?
The current annual shareholders equity of CLDX is $747.00M
What is the all time high annual shareholders equity for Celldex Therapeutics?
Celldex Therapeutics all-time high annual stockholders equity is $747.00M
What is Celldex Therapeutics annual shareholders equity year-on-year change?
Over the past year, CLDX annual stockholders equity has changed by +$317.83M (+74.06%)
What is Celldex Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of CLDX is $702.98M
What is the all time high quarterly shareholders equity for Celldex Therapeutics?
Celldex Therapeutics all-time high quarterly stockholders equity is $838.61M
What is Celldex Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, CLDX quarterly stockholders equity has changed by -$135.63M (-16.17%)